凯镛KAIYONG品牌怎么样 申请店铺

我要投票 凯镛KAIYONG在胶原蛋白粉行业中的票数:6 更新时间:2024-11-21
凯镛KAIYONG是哪个国家的品牌?「凯镛KAIYONG」是 天津凯镛药业有限公司 旗下著名品牌。该品牌发源于天津市,由创始人曹利东在1989-09-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
凯镛KAIYONG怎么样

天津凯镛药业有限公司是一家坐落于天津经济技术开发区的现代化制药企业,成立于1989年,公司注册资本为人民币4000万元。

公司是专业从事药品、保健品、食品的研发、生产、销售的高科技现代化企业,企业创始人为国际中医男科学会主席、中国中医药学会男科学会会长曹开镛教授。

公司拥有口服液车间与固体制剂车间,标准净化密闭制药厂房及生化工程设备,均具备国内专业水平。公司于2003年9月份顺利通过了国家药品生产规范考核标准的GMP认证。公司现有员工近200人,其中专业技术人员26%,均具备大学水平,各职能部门分工明确。

现公司产品品种共四十余种,规格众多,其中包括以凯镛乌鸡桂圆养血口服液、凯镛小儿咳喘灵口服液为代表的OTC药品6种,更有以曹开镛男士营养液、凯镛芦荟胶囊、凯镛蛋白粉、凯镛大豆异黄酮为代表的保健食品40余种,类型包括口服液、胶囊剂、粉剂、片剂、茶剂,基本涵盖了保健品的全部种类。

天津凯镛药业有限公司与各地各级代理商及终端连锁药房合作,公司内部销售人员予以支持辅佐,共同进行销售推广,无零售业务,产品销售终端已达3000余家。整体销售团队现有近百人,分级分区管理,权责分明,覆盖面广,渠道畅通。目前公司销售市场已覆盖全国各大省市,并且获得了用户的广泛好评和信赖。

2014年7月25日,天津凯镛药业有限公司生产研发基地建设(一期)项目正式开工,整个项目总建筑面积33956.12平方米。

目前,项目主体结构已封顶,二次结构已验收合格,预计完工时间为2016年末。新厂投产后,公司的生产规模、产能将得到整体提升。


Tianjin kaiyong Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise located in Tianjin Economic and Technological Development Zone. It was founded in 1989 with a registered capital of 40 million yuan. The company is a high-tech modern enterprise specializing in the research, development, production and sales of drugs, health products and food. The founder of the company is Professor Cao kaiyong, chairman of international society of andrology of traditional Chinese medicine and President of Andrology society of Chinese medicine. The company has oral liquid workshop, solid preparation workshop, standard purification closed Pharmaceutical Workshop and biochemical engineering equipment, all with domestic professional level. In September 2003, the company successfully passed the GMP certification of the national drug production standards. The company has nearly 200 employees, including 26% of professional and technical personnel, all of whom have university level and clear division of labor in each functional department. At present, the company has more than 40 kinds of products with various specifications, including 6 OTC drugs represented by kaiyong Wuji Guiyuan blood nourishing oral liquid, kaiyong Xiaoer Kechuanling oral liquid, and more than 40 health food represented by Cao kaiyong men's nutrition liquid, kaiyong aloe capsule, kaiyong protein powder and kaiyong soybean isoflavone, including oral liquid, capsule, powder, tablet Tea agent basically covers all kinds of health products. Tianjin kaiyong Pharmaceutical Co., Ltd. cooperates with agents at all levels and terminal chain pharmacies, with the support and assistance of the company's internal sales personnel to jointly carry out sales promotion. There is no retail business, and there are more than 3000 product sales terminals. The overall sales team now has nearly 100 people, who are managed in different levels and areas, with clear rights and responsibilities, wide coverage and smooth channels. At present, the company's sales market has covered all major provinces and cities in the country, and has been widely praised and trusted by users. On July 25, 2014, the construction of production and R & D base (phase I) of Tianjin kaiyong Pharmaceutical Co., Ltd. was officially started, with a total construction area of 33956.12 square meters. At present, the main structure of the project has been capped, the secondary structure has been accepted, and the expected completion time is the end of 2016. After the new plant is put into operation, the production scale and capacity of the company will be improved as a whole.

本文链接: https://brand.waitui.com/583df2b43.html 联系电话:15822503780

千城特选小程序码

7×24h 快讯

拼多多:第三季度营收增速环比下降,将坚定高质量发展战略应对竞争挑战

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多营收达到994亿元,与上个季度相比,营收的增速有所放缓。业内分析认为,一方面是因为电商行业的竞争依然激烈,另一方面是平台的“百亿减免”等举措影响了短期的财报表现。“为了应对行业竞争,我们将坚定地执行高质量发展战略,继续实行‘减免+扶持’的举措,持续完善平台及产业生态,为供需两侧带来更大的普惠。”拼多多陈磊表示。

48分钟前

拼多多:第三季度利润环比下降22%,将长期投入“新质供给”“电商西进”战略

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多利润达到250亿元,环比下降22%。过去这个季度,拼多多先后推出“百亿减免”“电商西进”“新质商家扶持计划”等重磅举措,持续扩大对生态建设的投资,一定程度上影响了短期的财报表现。拼多多陈磊表示,在财务数据之外,我们更加看重生态投资带来的长期价值,未来几个季度,拼多多将继续投入“新质供给”“电商西进”等战略,给用户、商家及产业带来更长远的回报。

48分钟前

莎普爱思:股东拟合计减持不超5%公司股份

36氪获悉,莎普爱思公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。

48分钟前

永杰新材上交所主板IPO申请获证监会同意注册批复

36氪获悉,证监会下发关于同意永杰新材料股份有限公司首次公开发行股票注册的批复,同意该公司首次公开发行股票的注册申请。根据招股书,该公司拟在上交所主板上市,公司专业从事铝板带箔的研发、生产与销售,产品主要包括铝板带和铝箔两大类。

48分钟前

东方电缆:公司及子公司近期中标合计约40亿元海底电缆项目

36氪获悉,东方电缆公告,公司及全资子公司东方海工院近期收到相关通知书,确认公司及东方海工院联合体为相关项目中标人。其中,直流海底电缆项目中标金额约15.14亿元,交流海底电缆项目中标金额合计约24.72亿元,以上项目合计中标金额约40亿元。同日公告,公司拟以自有资金投资建设东方中央研究院·总部项目,项目总投资金额约为5.54亿元。

48分钟前

本页详细列出关于颜如玉YOROYAL的品牌信息,含品牌所属公司介绍,颜如玉YOROYAL所处行业的品牌地位及优势。
咨询